No Data
No Data
Xinhua Pharmaceutical (000756.SZ): Pharmaceutical exports to the US and the US account for about 10% of the company's total sales
Gelonghui, April 17 | Xinhua Pharmaceutical (000756.SZ) said on the investor interactive platform that the company's pharmaceutical exports to the US, including the US, account for about 10% of the company's total sales.
Xinhua Pharma Unit's Cefaclor Capsules Passes Regulatory Evaluation
Shandong Xinhua Pharmaceutical (SHE:000756, HKG:0719) said cefaclor capsules, a drug of its unit Shandong Zibo Xinda Pharmaceutical, passed the quality and efficacy evaluation of China's National Medi
Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK) plans to hold a board meeting on April 25 to approve quarterly results
Gelonghui, April 11, 丨 Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK) announced that the company will hold a board meeting at 9:30 a.m. on April 25, 2024 (Thursday) in the company conference room No. 1, Lutai Avenue, High-tech Zone, Zibo City, Shandong Province. The contents of the meeting are as follows: 1. Review and approve the unaudited performance of the company and its subsidiaries for the three months ended March 31, 2024; and 2. Any other matters, if applicable.
Express News | National Health Insurance Administration: Nine batches of state-organized drugs collected domestically produced generic drugs, accounting for 96%
Accelerating the integration of obstetrics and medicine! How to deal with the “two ends” problem during the differentiation period of pharmaceutical innovation? Industry figures predict future internal volume reduction
① The 7th Pharmaceutical Innovation Ecology Conference (2024 Xipai Conference) with the theme of “Reconstructing R&D and Clinical Value Transformation Ecology through the Differentiation Period” opened in Zhangjiang, Shanghai. ② How to achieve original innovation with high quality and high value, and how to efficiently commercialize post-marketing products and achieve clinical value are the focus of this conference. ③ Many participants made a judgment that domestic pharmaceutical companies will reduce internal volume in the future.
Express News | Xinhua Pharmaceuticals: Cefaclor capsules passed the consistent evaluation of generic drug quality and efficacy
No Data